Skip to main content

CORRECTION article

Front. Neurol., 14 March 2023
Sec. Pediatric Neurology
Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1178132

Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases

This article is a correction to:

  1. Effectiveness of Mycophenolate Mofetil in the Treatment of Pediatric Anti-NMDAR Encephalitis: A Retrospective Analysis of 6 Cases

    1. Read original article
\nXiao-sheng Hao,Xiao-sheng Hao1,2Jiang-tao WangJiang-tao Wang2Chen ChenChen Chen2Yun-peng HaoYun-peng Hao2Jian-min Liang Jian-min Liang2*Song-yan Liu Song-yan Liu1*
  • 1The China-Japan Union Hospital, Changchun, China
  • 2The First Hospital of Jilin University, Changchun, China

A corrigendum on
Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases

by Hao, X.-s., Wang, J.-t., Chen, C., Hao, Y.-p., Liang, J.-m., and Liu, S.-y. (2020). Front. Neurol. 11:584446. doi: 10.3389/fneur.2020.584446

In the published article, there was an error regarding the affiliations. Instead of “1 The First Hospital of Jilin University, Changchun, China, 2 The China-Japan Union Hospital, Changchun, China”, it should be “1 The China-Japan Union Hospital, Changchun, China, 2 The First Hospital of Jilin University, Changchun, China”.

There was also an error regarding the affiliations for Xiao-sheng Hao. As well as having the affiliation “The First Hospital of Jilin University, Changchun, China”, they should also have the affiliation, “The China-Japan Union Hospital, Changchun, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: anti-N-methyl-D-aspartate receptor encephalitis, mycophenolate mofetil, pediatrics, efficacy, safety

Citation: Hao X-s, Wang J-t, Chen C, Hao Y-p, Liang J-m and Liu S-y (2023) Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases. Front. Neurol. 14:1178132. doi: 10.3389/fneur.2023.1178132

Received: 02 March 2023; Accepted: 03 March 2023;
Published: 14 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Hao, Wang, Chen, Hao, Liang and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Song-yan Liu, liu_sy@jlu.edu.cn/55783761@qq.com; Jian-min Liang, jackyliangjm@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.